RN7SL297P

Across TCGA pan-cancer cohorts, RN7SL297P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RN7SL297P data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher RN7SL297P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL297P expression acts as an unfavorable survival marker, although some lineages such as STAD and ESCA show a favorable association.

DLBC, MESO, and UCS are the cancer types where RN7SL297P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	III,IV	0.249	0.965	<.001	123	view →
MESO	OS	Tertile	All	0.255	0.568	<.001	54	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
STAD	OS	Tertile	IV	0.705	0.211	.011	25	view →
ESCA	DFS	Quartile	III,IV	0.540	0.234	.016	21	view →
LIHC	DFS	Tertile	All	0.378	0.572	.011	15	view →
KIRC	OS	Quartile	II,III,IV	0.382	0.566	.025	14	view →
LUAD	DFS	Tertile	All	0.556	0.320	.015	12	view →
TGCT	OS	Tertile	II,III,IV	0.752	1.000	.019	12	view →
BLCA	DFS	Tertile	III,IV	0.179	0.507	.002	9	view →
PRAD	DFS	Tertile	All	0.978	0.921	.046	6	view →
OV	DFS	Median	IV	0.344	0.556	.013	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RN7SL297P–DLBC (OS)

Open the DLBC breakdown →